XML 44 R27.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY COMPENSATION PLAN (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity
A summary of the Company’s stock option activity under its 2024 Plan for the year ended December 31, 2025 is as follows (in thousands, except for per share data and years):
Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term
(In Years)
Aggregate Intrinsic Value
Outstanding as of December 31, 2024
3,660 $15.84 
Granted378 $17.86 
Exercised(102)$15.79 
Forfeited(435)$15.86 
Outstanding as of December 31, 2025
3,501 $16.06 8.5$220,342 
Vested and exercisable as of December 31, 2025
1,295 $15.84 8.3$81,773 
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value
The weighted-average assumptions used by the Company to estimate the fair value of stock options granted under the 2024 Plan using the Black-Scholes option pricing model, as well as the resulting weighted-average fair value, for the years ended December 31, 2025 and December 31, 2024 were as follows:
 YEAR ENDED DECEMBER 31,
20252024
Risk-free interest rate3.91 %4.56 %
Expected volatility86.58 %86.32 %
Expected dividend yield— %— %
Expected term (in years)5.986.06
Weighted average fair value$13.32 $11.89 
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense for stock options under the 2024 Plan and 2017 Plan consisted of the following (in thousands):
 YEAR ENDED DECEMBER 31,
20252024
Research and development$6,534 $36,875 
General and administrative4,604 21,643 
Total stock-based compensation expense$11,138 $58,518